Some GLP-1s are now FDA approved for chronic weight management, including Wegovy (semaglutide) and Saxenda (liraglutide), ...

The acquisition includes clemizole hydrochloride (EPX-100), a potent, oral, centrally acting serotonin (5HT2) agonist. It is ...

As April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs ...

A study in Neuropharmacology reveals that a single dose of the psychedelic compound (R)-DOI significantly improves ...

There is some truth in this. When Dr Abraham was first prescribing GLP-1 agonist drugs he worked with a dietitian but ...

Big Pharma is jacking up prices for life-saving drugs to enrich its corporate executives. Now, as the Ohio Democrat seeks a ...

Discover how Vanda Pharmaceuticals' patent revolutionizes circadian rhythm disorder treatment with tasimelteon, tailored to patients' beta-adrenergic receptor antagonist use.

A first-in-class interleukin (IL)-15 receptor agonist, the drug is specifically approved in combination with BCG for adults ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal second quarter 2024 ...

The director of preventive cardiology at the University of Michigan, says the medications are a promising option for many ...

There are more than 50 glucagon-like peptide-1 receptor agonists (GLP-1RAs) in clinical development for Type 2 diabetes, ...

Gilead Sciences Inc. is aiming to capitalize on the early August 2022 buyout of privately held U.K. biotech Mirobio Ltd. with ...